Mark Mahaney, Evercore ISI head of internet research, joins 'Closing Bell' to discuss the markets, Meta's historic winning ...

Evercore ISI analyst David Raso maintained a Hold rating on Deere (DE – Research Report) yesterday and set a price target of $455.00. The ...

Evercore ISI analyst Michael Lonegan maintained a Hold rating on Entergy (ETR – Research Report) yesterday and set a price target of $86.00.

Magna International (NYSE:MGA – Get Free Report) (TSE:MG) had its price target reduced by stock analysts at Evercore ISI from ...

QuantumScape (NYSE:QS – Get Free Report) had its price target lowered by analysts at Evercore ISI from $10.00 to $8.00 in a ...

Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, explains why the bull market "can continue going," ...

In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against the other AI stocks. Tiger ...

Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6 ...

Evercore ISI has upgraded CRISPR Therapeutics (NASDAQ:CRSP) to outperform from in line, citing upcoming catalysts. The investment firm said it was now including the CTX320 and CTX310 in vivo ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (BRSE:1CG) from In-Line to Outperform. There are 577 funds or institutions reporting ...

Evercore ISI analyst Liisa Bayko raised the price target for CRISPR Therapeutics from $60.00 to $99.00. Bayko's optimism is driven by upcoming catalysts that could mark a new chapter for the company.